Literature DB >> 36051867

Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking.

Jing Zhang1, Zongyan Jiang1, Anbing Shi1,2.   

Abstract

After endocytosis, diverse cargos are sorted into endosomes and directed to various destinations, including extracellular macromolecules, membrane lipids, and membrane proteins. Some cargos are returned to the plasma membrane via endocytic recycling. In contrast, others are delivered to the Golgi apparatus through the retrograde pathway, while the rest are transported to late endosomes and eventually to lysosomes for degradation. Rab GTPases are major regulators that ensure cargos are delivered to their proper destinations. Rabs are localized to distinct endosomes and play predominant roles in membrane budding, vesicle formation and motility, vesicle tethering, and vesicle fusion by recruiting effectors. The cascades between Rabs via shared effectors or the recruitment of Rab activators provide an additional layer of spatiotemporal regulation of endocytic trafficking. Notably, several recent studies have indicated that disorders of Rab-mediated endocytic transports are closely associated with diseases such as immunodeficiency, cancer, and neurological disorders.
© 2022 The Authors.

Entities:  

Year:  2022        PMID: 36051867      PMCID: PMC9418685          DOI: 10.1016/j.csbj.2022.08.016

Source DB:  PubMed          Journal:  Comput Struct Biotechnol J        ISSN: 2001-0370            Impact factor:   6.155


Introduction

Cells can take in extracellular macromolecules, membrane phospholipids, and membrane proteins through endocytosis. As the primary method of intracellular transport, endocytic transport is involved in various processes, including nutrient uptake, cell polarity, cell migration, cell division, and synaptic transmission [43]. Intracellular transport involves endocytosis, sorting, recycling, and the degradation of macromolecules, phospholipids, and proteins; it is a highly complex regulatory network. Some membrane proteins and membrane phospholipids are transported to the lysosome for degradation. In contrast, the rest of the membrane proteins and membrane phospholipids are returned to the plasma membrane for reuse, allowing the plasma membrane to maintain structural and functional homeostasis [26]. The endocytic system consists of components such as Rab GTPases, cytoskeleton-based tracks for endocytic vesicle translocation, cytoskeleton-associated motor proteins, and vesicles that carry cargos. In eukaryotic cells, actin filaments and microtubules provide a pathway for endocytic transport. The myosin family drives vesicle movement along actin filaments, while the kinesin and dynein families cooperate to move vesicles along microtubules [75]. Rab GTPases are the most significant molecular switches in regulating endocytic transport. Notably, Rab GTPases are localized to diverse endosomal structures and regulate the functions of endosomes by recruiting various effectors (Fig. 1) [53]. A large body of evidence demonstrates that Rab proteins play pivotal roles in the formation, translocation, anchoring, and fusion of vesicles during endocytic transport [43].
Fig. 1

Rab GTPases are molecular switches for endocytic trafficking. Rab4 medicates fast endocytic recycling directly from the early endosome to the plasma membrane. Rab5, which is localized to the early endosome, mediates endosomal fusion of clathrin-coated vesicles and the maturation of early endosomes. Rab11 and Rab35 regulate the slow endocytic recycling (that delivers the cargo back to the cell surface) through recycling endosomes. Rab7 modulates the transport from late endosomes to lysosomes. Rab9 functions in the pathway from late endosomes to the Golgi apparatus. Rab10 is localized to sorting endosomes and operates in the route from sorting endosomes to recycling endosomes. RE: early endosome; SE: sorting endosome; RE: recycling endosome; LE: late endosome; TGN: trans-Golgi network; ER: endoplasmic reticulum.

Rab GTPases are molecular switches for endocytic trafficking. Rab4 medicates fast endocytic recycling directly from the early endosome to the plasma membrane. Rab5, which is localized to the early endosome, mediates endosomal fusion of clathrin-coated vesicles and the maturation of early endosomes. Rab11 and Rab35 regulate the slow endocytic recycling (that delivers the cargo back to the cell surface) through recycling endosomes. Rab7 modulates the transport from late endosomes to lysosomes. Rab9 functions in the pathway from late endosomes to the Golgi apparatus. Rab10 is localized to sorting endosomes and operates in the route from sorting endosomes to recycling endosomes. RE: early endosome; SE: sorting endosome; RE: recycling endosome; LE: late endosome; TGN: trans-Golgi network; ER: endoplasmic reticulum. Rab GTPases are monomeric GTP-binding proteins of approximately 200 amino acids in all eukaryotic cells. The human genome encodes more than 60 Rabs [4], [66], while there are only 31 Rab-like genes in C. elegans [37]. Furthermore, Rab isoforms involved in various endocytic transport can be produced by selectively splicing Rab genes [38]. Upstream regulators control the activity of Rab proteins, which then direct downstream effector proteins to perform specific functions. Irregular Rab-mediated endocytic steps can cause aberrant distribution of functional proteins, leading to physiological malformation and diseases. It is worth noting that newly synthesized Rabs are not modified by prenylation (farnesyl modification or geranylgeranyl modification). Once synthesized, the Rab is then transferred to farnesyl transferase or geranyl transferase, which will change the cysteines at the C-terminus of Rab proteins using farnesyl pyrophosphate or geranyl pyrophosphate, respectively [129]. The prenylated Rab is delivered to the target membrane, where the Rab is converted from the GDP-bound inactive form to the GTP-bound active form by the Rab guanylate exchange factor (GEF) and associates with the membranes of specific organelles. In contrast, those Rabs that GEF does not activate will reside in the cytoplasm by binding to the Rab GDP dissociation inhibitor (GDI) [98], [116]. The GTP-bound active form of Rab exerts its regulatory role in various ways by recruiting effectors. Multiple types of Rab effectors have been identified, including tether complexes [6], motor proteins and adapters [51], and proteins that mediate vesicle membrane fusion [92]. Of note, post-translational Rab modifications, such as phosphorylation, can regulate the interaction of Rabs with GDI, GEF, GTPase-activating proteins (GAPs), and effector proteins [96], [83], [49]. Rab4, Rab5, Rab7, Rab9, Rab10, Rab11, and Rab35 have been associated with endocytic trafficking. These Rabs are located in different endosomes or at different positions in the same endosome, where they regulate different steps of endocytic trafficking independently or cooperatively (Fig. 1) [93], [97]. For instance, two distinct Rab-mediated pathways can orchestrate the endocytic recycling of G protein-coupled receptors. Rab4 is mainly localized on early endosomes and regulates the recycling of receptors from early endosomes directly back to the plasma membrane (fast recycling pathway) [133]. Rab11 resides in the perinuclear recycling endosome, where it facilitates the delivery of receptors from the recycling endosome to the cell surface (slow recycling pathway) [130].

Rab4 is required for endosomal sorting and fast recycling

Rab4 is a well-known regulator of cargo sorting and fast recycling in the early endosome (Fig. 1) [132]. The binding of Rab4 to GTP or GDP and its affiliated functions are directly or indirectly regulated by other proteins or signaling molecules. Through a PI3K-independent route, the messenger molecule cAMP promotes Rab4 activation [114]. The phosphorylation of serine residue 213 of GDI can encourage the formation of the GDI-Rab4 complex and facilitate the functional cycle of Rab4 [77]. TBC1D16 was identified as a GAP of Rab4 that affects the localization of Rab4A in the endosomal membrane by enhancing the intrinsic GTP hydrolysis efficiency of Rab4A [42]. The Rab4 GTPase subfamily has three members: Rab4A, Rab4B, and Rab4C [38], whereas C. elegans has no ortholog or paralog. Rab4A and Rab4B mediate GLUT4 (Glucose Transporter 4) transport, thereby modulating glucose uptake [60]. According to researchers, Rab4B expression was significantly reduced in adipose tissue from obese diabetic patients and mice; Rab4B colocalizes with GLUT4 and affects insulin-stimulated glucose uptake in 3T3-L adipocytes. In contrast, Rab4A rarely overlaps with GLUT4, and downregulating its expression had little impact on basal or insulin-stimulated glucose uptake [60]. Therefore, Rab4A and Rab4B could have functional redundancy during recycling regulation, but they are likely to have different roles and mechanisms. The functional scenarios of Rab4C are still unknown and need further investigation. Several Rab4 effectors have been identified, including AKAP10/D-AKAP2, CD2AP/CMS, GRASP-1, NDRG1, Rip11/RCP, Rabaptin5/RABEP1/Rbpt5, RUFY1/Rabip4s, and ZFYVE20/Rabenosyn5 (Table 1). Eggers et al. showed that the RGS domain of D-AKAP2 alters the morphology of the Rab11 compartment and affects the recycling of the transferrin receptor by interacting with Rab4 and Rab11 [31]. Along with Rab4, RUFY1/Rabip4s affect NIH 3T3 fibroblasts migration and adhesion by regulating integrin transport [135] and affect glucose uptake by regulating endocytosis and transport of GLUT4 in adipocytes [80]. Furthermore, Rab4 participates in a small GTPase cascade by promoting Arl1 recruitment to early endosomes, which supports the association of endosomal sorting sites with clathrin complexes and affects early endosomal sorting [27].
Table 1

Rab proteins and their effectors in endocytic transport.

RabEffectorFunctionReferences
Rab4AKAP10/D-AKAP2Transferrin receptor recycling[31]
CD2AP/CMSEndosome morphology and lysosomal degradation[25]
GRASP-1Maturation of recycling endosome[50]
NDRG1Recycling of E-cadherin[59]
Rip11/RCPEndosomal recycling[71]
Rabaptin5/RABEP1/Rbpt5Endosome maturation[61]
RUFY1/Rabip4sEndocytic recycling[135]
ZFYVE20/Rabenosyn5Endocytosis[126]
Rab5Rabaptin5/RABEP1/Rbpt5Endosome maturation[61]
ZFYVE20/Rabenosyn5PI3P level on early endosomes[86]
Mon1/SAND-1Early-to-late endosomes conversion[63]
EEA1/EEA-1Endosomal membrane fusion[40]
Erbin/LET-413RAB-10 activity[74]
Rab7RILPLate endosome to lysosome trafficking[11]
FYCO1Microtubule plus end-directed vesicle transport[95]
Retromer complex(Vps26, Vps29, and Vps35)Late endosome to Golgi trafficking[107]
Rabring7EGF receptor degradation[108]
Rab9TIP47Receptor recruitment[13]
p40Endosome-to-TGN transport[28]
Nde1Interaction between late endosomes and dynein[154]
RUTBC1/2/TBC-8N/A[90], [91]
GCC185Endosome-to-TGN transport[102]
Rab10TBC-2Endocytic recycling[76]
ACAPs/CNT-1Endocytic recycling[120]
EHBP1/EHBP-1Endocytic recycling[118], [136]
SEC16AInsulin-stimulated GLUT4 trafficking[7]
Rab11Rab11BP/Rabphilin-11Endocytic recycling[78], [146]
Rip11/RCPEndosomal recycling[71]
myosin VbRab11-FIP2-dependent recycling[46], [85]
Rip11/pp75Apical recycling[101]
Rab11-FIP1/FIPP-1Rab11-dependent recycling[46]
Nuf/Rab11-FIP3/Arfophilin2Membrane traffic in cytokinesis[12]
Rab11-FIP4/RFIP-1Membrane traffic in cytokinesis[33]
Sec15Exocyst function in recycling[151]
Rab35OCRL/OCRL-1Membrane traffic in cytokinesis[15]
FascinActin Bundling during cell migration[147]
RUSC/NESCARab35 activity[35]
MICAL-L1Membrane traffic during neurite outgrowth[68]
centaurin-β2/ACAP2/CNT-1Membrane traffic during neurite outgrowth[67]
Rab proteins and their effectors in endocytic transport. Rab4 is influenced by multiple regulatory factors, regulates multiple effectors, and is involved in intracellular transport by affecting many intracellular biological functions. However, the molecular mechanisms of how Rab4 circulates in the endosome, how it precisely controls protein cargo-dependent transport pathways, how it cooperates with other GTPases to control vesicle aggregation, fusion, and targeted transport, how it controls metabolic and signaling pathways, and the temporal and spatial control of its function are all poorly understood. Current studies only partially explain these processes, and more research is needed to fully elucidate the mechanism of Rab4.

Rab5 directs biogenesis and functions of early endosomes

Rab5 plays a crucial role in endocytic transport, regulating vesicle transport from the plasma membrane to the endosome (Fig. 1). In particular, Rab5 promotes the fusion of nascent endocytic vesicles with early endosomes and fusion between early endosomes, so it is often used as a marker for early endosomes [141]. Studies in various systems have revealed multiple Rab5 GEF proteins, including RABX-5/Rabex-5 [109], [150], [149], [153], hRME-6/RME-6 [112], and Rin2/RIN-1 [29]. RABX-5/Rabex-5 is the first protein identified as a small GTPase GEF and is primarily localized at early endosomes [52]. During degradation transport from early to late endosomes, SAND-1 displaces RABX-5 from endosomal membranes and interacts with the core components of the HOPS (the homotypic fusion and vacuole protein sorting) complex to promote RAB-7/Rab7 activation and facilitate early-to-late endosome conversion [99]. RME-6, in concert with the adaptor protein APA-2, localizes to the clathrin-coated pits and vesicles, where it activates RAB-5 to promote the transit of cargos to early endosomes [112]. In C. elegans, the functions of RABX-5 and RME-6 were found to be partially redundant. Only simultaneous knockdown of RABX-5 and RME-6 led to almost complete dissociation of RAB-5 from early endosomes [112]. Studies on RIN-1 were primarily performed in the C. elegans nervous system. As an effector, RIN-1 also specifically binds to the active form of CED-10/Rac1 to regulate actin remodeling and directs the directional migration of neuronal cells and axon pathfinding [29]. Given that the overactivation of Rab proteins can adversely affect endocytic trafficking, it is crucial for TBC-2, a Rab5/RAB-5 GAP, to shut down RAB-5 activity in a timely manner [22]. Zhang et al. found that RAB-5 resides in discrete endosome subpopulations in the intestine of C. elegans, and under the oversight of CED-10, LET-502 synergizes with RABX-5 to revitalize RAB-5 on a subset of endosomes in the deep cytosol, ensuring the progress of basolateral recycling [150], [149], [153]. USP6NL/RN-tre is thought to be a GAP shared by Rab5 and Rab41, while TBC1D2/Armus/TBC-2 appears to function primarily as a GAP for Rab7 [22], [34]. Recent studies on endocytic trafficking indicated that Rab5/RAB-5 effectors range from Rabaptin5/RABEP1/Rbpt5, ZFYVE20/Rabenosyn5/RABS-5, Mon1/SAND-1, Erbin/LET-413, and EEA1 (Table 1). Among them, RABS-5(Rabenosyn5) and its binding protein VPS-45, as well as VPS-34, act during the endosome fusion process [41]. Vps34 is phosphatidylinositol 3-kinase (PI3K) that phosphorylates phosphatidylinositol to generate phosphatidylinositol-3-phosphate (PI3P) at early endosomes [84], [70]. In addition, Vps34 is known to form complexes with Beclin/BEC-1 and P150/VPS-15 to function during autophagy and other transport events [36]. Further work on C. elegans has revealed that RAB-5 recruits LET-413 to promote DENN-4 GEF activity toward RAB-10 on sorting endosomes [74]. As a Rab5 effector essential for endosome fusion, EEA1 is in a homodimeric configuration, forming a complex with Rab5 and specifically binding to PI3P [40]. As a common effector of Rab5 and Rab4, Rabaptin5/RABEP1/Rbpt5 interacts with the membrane remodeling protein EHD1 to regulate endosome morphology and contribute to endocytic transport [144], [61]. In addition to regulating the fusion of early endosomes, Rab5 also plays a vital role in upstream events of the endocytosis process. Clathrin-dependent endocytosis (CDE) starts with clathrin and AP2 complex coated vesicles (CCVs), which are formed by the invagination of the plasma membrane. After uncoating clathrin, these vesicles fuse with similar vesicles or early endosomes. The AP2 complex is a heterotetramer (subunits α/β2/µ2/σ2) and acts as a significant adaptor in CDE. μ2-adaptin specifically recognizes the intracellular region of cargo proteins and can be phosphorylated by μ2 kinase bound to α-adaptin [64], [54]. After being phosphorylated, μ2-adaptin can strongly bind to phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) and encourage AP2 assembly [106]. It has been reported that dominant-negative Rab5(S34N) overexpression or the small siRNA-mediated knockdown of hRME-6 enhances AP2 levels while reducing the efficiency of CCV uncoating [117]. However, the loss of another Rab5 GEF, Rabex-5, does not lead to this phenotype. Further mechanistic dissection demonstrated that hRME-6 could competitively bind to the site on μ2 kinase AAK1 that interacts with α-adaptin. This interaction dissociates AAK1 from α-adaptin, thereby reducing the phosphorylation level of μ2-adaptin and promoting the uncoating of the AP2 complex [117]. It should be noted that overexpression of Rab5(S34N) also increases the level of PI(4,5)P2 in CCVs and thus impairs AP2 uncoating [111], [20]. Together, Rab5 and its GEF protein hRME-6 regulate AP2 uncoating by modulating μ2-adaptin dephosphorylation and PI(4,5)P2 levels, suggesting that Rab5 plays a role in regulating AP2 complex dissociation from CCVs. By recruiting its effectors, Rab5 influences the internalization and intracellular translocation of several signal transduction receptors, including receptor tyrosine kinases (RTKs), G protein-coupled receptors (GPCRs), and antigen recognition receptors. Gene transcription could be impacted by the aberrant function or expression of Rab5, which could then affect cell shape, proliferation, differentiation, and apoptosis—any of which could result in illness [58]. Continued research on Rab5 has improved our understanding of the endocytic system, particularly the dynamic sorting regulatory mechanism of sorting endosomes. The endosome is not a static compartment used to transport cargo; rather, it is a sophisticated and finely regulated dynamic network system. However, there are still many unanswered concerns regarding Rab5′s regulatory processes, including which endosomal sorting tasks rely on it, how to coordinate these functions, and how it contributes to diseases. By addressing these fundamental issues, we can gain a better understanding of the regulatory system that controls vesicular transport, shed light on how Rab5 functions during both development and pathological condition, and create new opportunities for therapeutic interventions in related diseases.

Rab7 and Rab9 are associated with the regulation of late endosome function

The mutation or dysfunction of Rab7 is associated with various diseases, such as neurological disorders, cancer, and lipid metabolic disorders [147]. Rab7 is stably present on late endosomes (Fig. 1), and the SAND-1/CCZ-1 complex functions as a GEF for Rab7/RAB-7 [100], [87], [89]. It has been demonstrated that Rab7 is a critical regulator of endosomal degradation, which mediates the maturation of early endosomes to late endosomes along with its effector HOPS complex [3]. In addition, Rab7 is involved in the biogenesis of lysosomes, phagosomes, autophagosomes, and other lysosome-associated organelles (LRO) [8], [55]. By interacting with the Rab-interacting lysosomal protein (RILP), Rab7 also affects the morphology and spatial distribution of lysosomes by regulating the cytoskeleton [137]. In addition to Rab7, late endosomes often carry another Rab member, Rab9 (Fig. 1). However, Rab7 and Rab9 are recruited to the endosomal membrane via different mechanisms and are present in different subdomains of the same endosome [125]. Mammalian Rab9 has two isoforms, Rab9A and Rab9B, which share 87 % homology, and their GTP-bound forms display nearly identical structures [154]. There is no homolog of Rab9 in C. elegans. Notably, Rab9 is also known to play a role in lysosomal enzymes sorting to late endosomes, as well as lysosomes and LRO biogenesis, even though it is not directly involved in endosome maturation [103], [65]. TIP47, GCC185, p40, RUTBC1/2, and NdeI are Rab9 effectors (Table 1). Notably, Rab9A increases the affinity of TIP47 for CI-MPRs by promoting the recruitment of TIP47 to endosomes containing mannose-6-phosphate receptors (CI-MPRs) [13]. Likewise, GCC185 and Rab9A are required to transport CI-MPRs from late endosomes to the trans-Golgi network [102]. Recently, Nde1 was revealed to mediate the interaction of Rab9A with Lis1, dynein, and dynactin for the retrograde trafficking of late endosomes to TGN [154]. Rab9 is also involved in the Golgi targeting of glycosphingolipids internalized via caveolae [23]. In addition, Rab9-mediated fusion of the isolation membrane with TGN and late endosome vesicles is required for autophagosome formation in unconventional macroautophagy [88]. Likewise, Rab7 has been implicated in promoting the maturation of autophagosomes [140]. However, it is unclear how Rab7 and Rab9 are differentiated and recovered, as well as which protein complexes are involved in Rab9-mediated cargo protein transport. Rab7 plays an integral role in neurons [56], and neuronal homeostasis can be disrupted when Rab7 activity or expression is altered, leading to the development of multiple neurological disorders, such as AD, Parkinson's disease, Huntington's disease, and Lewy body dementia [140]. However, the precise function of Rab7 in the pathophysiology of various illnesses and the processes by which it contributes to the emergence of disease are still poorly understood.

Rab10 is a molecular switch for polarized sorting and recycling transport

Rab10 is mainly located on sorting endosomes and regulates polarized transport in epithelial cells (Fig. 1) [2], [115]. Interestingly, Rab10 was also found in perinuclear Golgi/TGN in nonpolar fibroblastic baby hamster kidney (BHK) and Chinese hamster ovary (CHO) cells [19]. Rab10 mediates transport from basolateral sorting endosomes to common endosomes in polarized MDCK cells [2]. The expression of activated Rab10(Q68L) was shown to prevent translocation of the vesicular stomatitis virus G glycoprotein (VSV-G) to the basolateral membrane in subsequent research. Instead, VSV-G was missorted to the apical membrane in MDCK cells [115]. Similarly, Rab10 and its GAP protein, AS160, regulate the trafficking of GLUT4 to the plasma membrane in response to insulin in 3T3-L1 adipocytes [110]. By regulating lipid synthesis, Rab10 also contributes to the development of membrane tubules and the maintenance of ER (endoplasmic reticulum) dynamics [17]. In a recent study in C. elegans, it was discovered that LET-413/Erbin, a RAB-5 effector, can promote RAB-10 activation by releasing the autoinhibitory configuration of RAB-10 GEF DENN-4 during endocytic recycling [74]. Numerous effectors, including CNT-1/ACAPs/Arf-GAP and EHBP-1, were discovered by studying Rab10/RAB-10 [118], [120]. In C. elegans, RAB-10 recruits CNT-1 to basolateral recycling endosomes, where CNT-1 negatively regulates ARF-6/Arf6 activity and reduces the abundance of the ARF-6 effector PI5K on the endosomal membrane, lowering the PI(4,5)P2 levels in recycling endosomes [120], [119], [18]. In recycling endosomes, RAB-10 also promotes membrane budding by regulating F-actin bundling via its effector EHBP-1 [118], [136]. A subsequent study further demonstrated that EHBP-1 facilitates recycling endosomal tubule fission by recruiting SID-3 and DYN-1/dynamin sequentially [39]. With the assistance of RAB-10 and AMPH-1/Amphiphyin, TBC-2/RAB-5-GAP, an effector of CED-10 [127], can also be recruited to endosomes for recycling regulation [76]. Additionally, recent research has revealed that the interaction between myosin Vb and Rab10 can control the vesicular transport from the trans-Golgi [45]. Numerous cancers, including hepatocellular carcinoma, glioma, cervical cancer, osteosarcoma, etc., exhibit high expression of Rab10 [57], [138], [47], [150], [149], [153], which affects the prognosis of tumors and controls the apoptosis, proliferation, migration, invasion, and autophagy processes of tumor cells [155]. In addition, the aberrant phosphorylation of Rab10 may contribute to the altered vesicular transport in Alzheimer's disease. It is unclear how the activity of Rab10 is turned off in time or what controls the aberrant phosphorylation of Rab10. The mechanism of Rab10 in both physiological states and pathological conditions, as well as its potential clinical applications, requires further study.

Rab11 is a key regulator of the slow recycling route

As a major regulator of the dynamics of endocytic transport, functional irregularities in Rab11 can cause tumor progression and invasion [32]. The human Rab11 gene family has three isoforms: Rab11A, Rab11B, and Rab25/Rab11C. RAB-11.1 and RAB-11.2 are present in C. elegans. Rab11A is present in most human tissues, while Rab11B and Rab25 are exclusively enriched in specific organs [139]. All three isoforms of Rab11 are subject to post-translational modifications, including isoprenylation, phosphorylation, and ubiquitination. The isoprenylation of the Rab11 C-terminus assists in targeting Rab11 to the endosomal membrane, while phosphorylation and ubiquitination regulate the activity and degradation of Rab11, respectively [139]. Notably, three isoforms of Rab11 perform distinct cellular functions. Rab11A regulates the endocytic transport from or through the recycling endosome to the plasma membrane [130], [81]. Additionally, Rab11A mediates lipid transport from sorting endosomes to the recycling endosome [10]. Rab11A is also observed in TGN, where it regulates the secretory transport to the apical and basolateral membranes [32]. Rab11B is highly enriched in sorting and recycling endosomes in the brain. However, the loss of Rab11B failed to cause an accumulation of transferrin receptors [128]. Interestingly, Rab11A and Rab11B could play opposite roles in the same cellular context, with Rab11B controlling the recycling of PAR-1 from endosomes to the plasma membrane and Rab11A promoting PAR-1 degradation by delivering this signaling receptor to the autophagic pathway [44]. In addition, Rab11B mediates secretory transport in polarized epithelial cells and neurons [62], [122]. Rab25 interacts directly with the α5β1 integrin located at the pseudopod of migrating cells and confines it to the pseudopod site, thus promoting the invasive migration of tumor cells [14]. In addition, Rab25 and CLIC3 (chloride channel protein 3) synergistically regulated integrins from the late endosome to the dorsal surface of migrating cells, thus promoting tumor cell invasion [30]. Rab11BP/Rabphilin11, the first discovered Rab11A effector (Table 1), has been associated with transferrin recycling [78], [146]. Myosin Vb, the Rab11A-interacting effector, was screened from a rabbit cDNA library [46]. Consistently, Myosin Vb is involved in recycling transport by mediating the movement of vesicles along actin filaments [85]. Moreover, six Rab11 family interacting proteins (Rab11-FIPs) have been identified. Class I FIPs consist of Rip11 (also known as pp75 or FIP5), RCP (Rab11 coupling protein), and FIP2. Rip11 is recruited by endosomal Rab11 and cooperates with RCP to regulate transport from recycling endosomes to the apical membrane [101], [72]. Class II members (FIPs, FIP3/Arfophilin/Eferin, and FIP4) are involved in regulating transport from recycling endosomes to the cleavage furrow, facilitating cytoplasmic division [33]. FIP1, which colocalizes with Rab11 and likely assists Rab11 in specific recycling transport, is currently the only class III member [46]. Rab11 is a known overexpressed protein that has a role in the proliferation and invasion of malignant tumors, such as rectal, gastric, esophageal, skin, and breast cancers [5], [143], [152], [94]. However, the mechanism governing the involvement of Rab11 in tumor cell proliferation and apoptosis inhibition is not well defined.

Rab35 is a regulator of cargo recycling and actin remodeling

It has been demonstrated that Rab35 regulates the endocytic recycling of various protein cargos and actin dynamics [24], [79]. Unlike Rab11, Rab35 regulates a slow recycling route that coordinates cell adhesion and migration (Fig. 1) [1], making Rab35 a new area of interest for endosomal research. Rab35 is localized to the clathrin-coated pits/vesicles and endosomal membranes, regulating the endocytic recycling of cargo proteins [69]. Rab35 has also been involved in recycling synaptic vesicles [131]. Moreover, Rab35 promotes actin reorganization during filopodia formation and protrusive membrane extension in cultured cells [148], [79]. A study using PC12 cells revealed a role for Rab35 in the maintenance of PI(4,5)P2 level [67]. The recruitment of PI(4,5)P2-binding proteins involved in membrane bending and fission is specifically regulated by the Rab35-to-Arf6 cascade, which also controls endosomal PI(4,5)P2 levels. Arf6(GTP) can negatively regulate Rab35 activity in human cells by interacting with the Rab35 GAP EPI64B [21]. Indeed, a similar Rab-to-Arf cascade has been discovered in the regulation of recycling transport in C. elegans [120], [119]. These findings suggested that crosstalk between different types of small GTPases is a conserved mechanism that could be significant for endocytic transport. In C. elegans, RAB-35 is required for clathrin-based receptor-mediated endocytosis of yolk proteins [113]. The importance of fully comprehending the molecular pathways regulated by Rab35 is highlighted by the fact that Rab35 or its regulators are associated with diseases such cancer [16]. Through a cooperative relationship between membrane trafficking mediated by Rab family proteins and activation of oncogenic signals, Rab35 controls the development of tumors [145], [134]. While Rab35 is implicated in the regulation of a number of cancers, its exact function is not yet clear and requires further research.

Two-way cascades between Rab proteins

The identity of distinct membrane compartments is defined by specific Rab proteins. To ensure effective membrane trafficking, it is important to convert the identity of the endosomal compartment [99]. Of note, Rab cascades are involved in converting endosomal compartment identities [99], [53]. GEFs of downstream Rabs are recruited by upstream Rabs. In turn, upstream Rab GAPs are then recruited by downstream Rabs after their activation, which stops the activity of the upstream Rab. Therefore, the two-way Rab cascades (Rab-GEF forward cascade and Rab-GAP reverse cascade) can change the molecular composition of the membrane and, thus, the properties of endosomal compartments. For instance, the HOPS complex, an effector of Rab5, is recruited to early endosomes by binding Rab5. Then, Rab7 is activated by the HOPS complex via its VPS39/GEF subunit [142], [9]. Furthermore, active RAB-7/Rab7 has been shown to recruit the effector TBC-2/RAB-5-GAP to inactivate upstream RAB-5/Rab5 [22]. In C. elegans, similar cascade-mediated regulation has been found to sustain endocytic recycling. TBC-2 is capable of binding to the active RAB-10(GTP) but not the inactive RAB-10(GDP), and the interface mediating TBC-2 binding to RAB-10 is not the GAP domain of TBC-2 [76]. RAB-10, a key regulator of early-to-recycling endosomal transport, shuts down upstream RAB-5 activity by recruiting TBC-2, forming a GAP reverse cascade [76]. Recently, in C. elegans intestinal cells, LET-413/Erbin was found to act as an effector of RAB-5/Rab5, synergizing with DENN-4/RAB-10-GEF to activate downstream RAB-10 [74]. This study provides a forward GEF cascade mechanism that further clarifies the regulatory process of recycling transport.

Post-translational modifications affect Rabs efficacy

Although the function of Rabs is typically coordinated by regulators such as GAPs and GEFs, recent studies have revealed that some Rabs are phosphorylated by Rab kinases in the switch II region, inhibiting binding to Rab interactors [124]. Furthermore, the conformational change of the switch II region depends on nucleotide binding, so the phosphorylation described above can significantly affect the structure and function of the switch region. Indeed, new evidence is emerging that phosphorylation regulates Rabs function, some of which are implicated in diseases such as Parkinson’s disease and cancer [156], [105]. Given the importance of Rabs post-translational modifications, biochemical assays such as mass spectrometry and proximity-dependent biotinylation allow us to learn more about the functional mechanisms of Rabs by finding new types of post-translational modifications. In addition, cryo-electron microscopy analysis of non-crystalline protein structure makes it possible to study high molecular weight Rab-effector complexes. Future studies are required to elucidate the details of post-translational modifications in regulating Rabs function, thereby helping to understand the role of Rab kinases in the interaction between disease-related signaling and endocytic trafficking.

Conclusions

Rabs act as regulatory switches for endocytic transport, directly or indirectly affecting endosomal functions by recruiting various effector proteins (Fig. 1; Table 1). For example, the well-studied Rab5 recruits the PI3K to synthesize PI3P and then recruits PI3P-binding proteins to form the functional endosome domain (membrane property regulation) [121]. Rab5 also recruits Rabenosyn-5 and EEA1 to facilitate endosomal fusion (membrane fusion regulation) and activates downstream Rab7 to promote endosome maturation (Rab cascade) [123], [86], [104]. Moreover, Rab5 is essential for clathrin-mediated TfR endocytosis and clathrin-coated vesicle formation (membrane budding regulation) [82]. Subsequently, endosomal Rab5 recruits the phosphatases OCRL and Inpp5b to reduce PI(4,5)P2 levels and encourages membrane tubule fission (membrane fission regulation) [111]. Rab5 also indirectly affects the function of microtubule motor kinesin by regulating PI3P levels (vesicle motility regulation) [48]. Rab5 recruits the effector Rabaptin-5, which cooperates with Rabex-5 to promote its own activity (Rab activity regulation) [73]. Compared with Rab5, studies on other Rabs have primarily focused on elaborating a specific working mode, and many functional nodes are missing in the regulatory networks. Subsequent research should use multicellular in vivo models to identify new Rab-binding proteins and associated regulatory elements, promoting a comprehensive and systematic understanding of endocytic transport's operational process and regulation.

CRediT authorship contribution statement

Jing Zhang: Conceptualization, Validation, Writing – original draft, Writing – review & editing. Zongyan Jiang: Visualization. Anbing Shi: Conceptualization, Supervision, Validation, Writing – original draft, Writing – review & editing, Funding acquisition.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  155 in total

1.  An ARF6/Rab35 GTPase cascade for endocytic recycling and successful cytokinesis.

Authors:  Laurent Chesneau; Daphné Dambournet; Mickaël Machicoane; Ilektra Kouranti; Mitsunori Fukuda; Bruno Goud; Arnaud Echard
Journal:  Curr Biol       Date:  2012-01-05       Impact factor: 10.834

2.  Vps41 phosphorylation and the Rab Ypt7 control the targeting of the HOPS complex to endosome-vacuole fusion sites.

Authors:  Margarita Cabrera; Clemens W Ostrowicz; Muriel Mari; Tracy J LaGrassa; Fulvio Reggiori; Christian Ungermann
Journal:  Mol Biol Cell       Date:  2009-02-04       Impact factor: 4.138

3.  The VPS34 PI3K negatively regulates RAB-5 during endosome maturation.

Authors:  Fiona Law; Jung Hwa Seo; Ziqing Wang; Jennifer L DeLeon; Yousstina Bolis; Ashley Brown; Wei-Xing Zong; Guangwei Du; Christian E Rocheleau
Journal:  J Cell Sci       Date:  2017-04-28       Impact factor: 5.285

4.  Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression.

Authors:  Pierre-Luc Boulay; Louise Mitchell; Jason Turpin; Julie-Émilie Huot-Marchand; Cynthia Lavoie; Virginie Sanguin-Gendreau; Laura Jones; Shreya Mitra; Julie M Livingstone; Shirley Campbell; Michael Hallett; Gordon B Mills; Morag Park; Lewis Chodosh; Douglas Strathdee; Jim C Norman; William J Muller
Journal:  Cancer Res       Date:  2016-03-01       Impact factor: 12.701

5.  Rab35 establishes the EHD1-association site by coordinating two distinct effectors during neurite outgrowth.

Authors:  Hotaka Kobayashi; Mitsunori Fukuda
Journal:  J Cell Sci       Date:  2013-04-09       Impact factor: 5.285

6.  Rab4 orchestrates a small GTPase cascade for recruitment of adaptor proteins to early endosomes.

Authors:  Ryan S D'Souza; Rachel Semus; Emily A Billings; Corey B Meyer; Kathryn Conger; James E Casanova
Journal:  Curr Biol       Date:  2014-05-15       Impact factor: 10.834

7.  Rab11-FIP3 and FIP4 interact with Arf6 and the exocyst to control membrane traffic in cytokinesis.

Authors:  Andrew B Fielding; Eric Schonteich; Johanne Matheson; Gayle Wilson; Xinzi Yu; Gilles R X Hickson; Sweta Srivastava; Stephen A Baldwin; Rytis Prekeris; Gwyn W Gould
Journal:  EMBO J       Date:  2005-09-08       Impact factor: 11.598

Review 8.  Molecular control of Rab activity by GEFs, GAPs and GDI.

Authors:  Matthias P Müller; Roger S Goody
Journal:  Small GTPases       Date:  2017-02-01

9.  FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end-directed vesicle transport.

Authors:  Serhiy Pankiv; Endalkachew A Alemu; Andreas Brech; Jack-Ansgar Bruun; Trond Lamark; Aud Overvatn; Geir Bjørkøy; Terje Johansen
Journal:  J Cell Biol       Date:  2010-01-25       Impact factor: 10.539

10.  The C. elegans rab family: identification, classification and toolkit construction.

Authors:  Maria E Gallegos; Sanjeev Balakrishnan; Priya Chandramouli; Shaily Arora; Aruna Azameera; Anitha Babushekar; Emilee Bargoma; Abdulmalik Bokhari; Siva Kumari Chava; Pranti Das; Meetali Desai; Darlene Decena; Sonia Dev Devadas Saramma; Bodhidipra Dey; Anna-Louise Doss; Nilang Gor; Lakshmi Gudiputi; Chunyuan Guo; Sonali Hande; Megan Jensen; Samantha Jones; Norman Jones; Danielle Jorgens; Padma Karamchedu; Kambiz Kamrani; Lakshmi Divya Kolora; Line Kristensen; Kelly Kwan; Henry Lau; Pranesh Maharaj; Navneet Mander; Kalyani Mangipudi; Himabindu Menakuru; Vaishali Mody; Sandeepa Mohanty; Sridevi Mukkamala; Sheena A Mundra; Sudharani Nagaraju; Rajhalutshimi Narayanaswamy; Catherine Ndungu-Case; Mersedeh Noorbakhsh; Jigna Patel; Puja Patel; Swetha Vandana Pendem; Anusha Ponakala; Madhusikta Rath; Michael C Robles; Deepti Rokkam; Caroline Roth; Preeti Sasidharan; Sapana Shah; Shweta Tandon; Jagdip Suprai; Tina Quynh Nhu Truong; Rubatharshini Uthayaruban; Ajitha Varma; Urvi Ved; Zeran Wang; Zhe Yu
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.